Abingworth Exceeds Target on Latest Life-Sciences Fund

U.K. life-sciences investor Abingworth said it has closed a new fund with $315 million. The vehicle, Abingworth Bioventures VII LP, exceeded its $300 million target. Placement agent Asante Capital Group helped raise the fund. Abingworth has invested in more than 145 life-sciences companies and raised 12 life-sciences funds since its founding in 1973.

READ FULL ARTICLE ON WSJ PRO

jpeg 22

Other News

            

Asante 2018 Global Market Survey

18/12/2018

2018 proved to be another remarkable year for the private markets as fundraising numbers broke previous records – further evidence that the balloon is now nearing the stratosphere and it’s a long way down! We hope you enjoy it on our LinkedIn profile. Whilst you’re at it, if you get a chance to cast your […]

READ FULL ARTICLE >

Private Equity International Awards 2018

13/12/2018

The Asante Team are delighted to announce that we have been shortlisted by Private Equity International for the “Placement Agent of the Year” Awards 2018 – and for the first time across all of the European, Asian and North American categories. We’re incredibly proud of our team who have worked relentlessly this year to close […]

READ FULL ARTICLE >

Africa Service Providers Awards Winner 2018

23/10/2018

Asante Capital Group has been awarded placement agent of the year at the 2018 Africa Global Service Providers Awards. The AGF Africa Service Providers Awards were created to honor and generate both industry and public recognition of the outstanding efforts and accomplishments of fund service providers covering Africa. The AGF Africa Service Providers Awards is […]

READ FULL ARTICLE >